Round Bottom Breakout done. Good for Short term and Long term. Target 480 , 600, 750. Do Like ,Comment , Follow for regular Updates... Disclaimer : This is not a Buy or Sell recommendation. I am not SEBI Registered. Please consult your financial advisor before making any investments . This is for Educational purpose only.
A Bullish Breakout of On Neck pattern and a Rounding Bottom is visible on the Daily chart of NSE:SPARC MACD gave Positive crossover on Daily, Weekly and Monthly chart. So, expecting the momentum to continue. One can create a fresh position in the scrip as per the levels mentioned on the chart. Risk Disclaimer: The information provided in this analysis is...
NSE:SPARC Sun Pharma Advance Research Co Ltd can take support from 232 or break 270. We can buy near 232 and can see long term move above 270 with SL of 210 . Major targets levels are highlighted in blue lines.
Symbol: SPARC Close: 273.05 Today's Volume: 10961383 Sector: Healthcare Go Long above: 278.85 Stop Loss: 223.6 Resistance & Support: 📉 R: 282 || 291 || 303 📈 S: 261 || 249 || 240
Inverse Cup and Handle has formed over the last month for the retail giant. The price yesterday broke below the Brim level. This makes it bearish for downside to come. 200>21>7 RSI<30 Target R103.61 SMC - Above the Handle of the Cup is a Buy Side Liquidity Order Block. This is where Long traders BOUGHT and Short Traders got stopped. Where the BUYING took...
#AUROPHARMA NSE: AUROPHARMA CMP: 437 TP: 535 SL: 400 TF: <6m RR > 3.5 times Return > 22% THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest...
#CIPLA NSE: CIPLA CMP: 1128 TP: 1250 SL: 1080 TF: <6m RR > 2.5 times Return > 11% THYROCARE CNXPHARMA LUPIN NSE: CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest...
#THYROCARE NSE: THYROCARE CMP: 700 TP: 920 SL: 600 TF: <6m RR > 2.3 times Return > 30% THYROCARE CNXPHARMA LUPIN CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs &...
📊 Script: SPARC (SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED) 📊 Nifty50 Stock: NO 📊 Sectoral Index: NIFTY PHARMA 📊 Sector: Healthcare 📊 Industry: Pharmaceuticals & Biotechnology Key highlights: 💡⚡ 📈 Script is trading at upper band of BB and giving Breakout. 📈 MACD is giving crossover. 📈 Crossover in Double Moving Averages. 📈 Right now RSI is around 73. ⏱️...
SPARC CMP 235 Buy Above 251 Target 300/310 Swing /Positional trade
Kindly read chart carefully. Trade details are for educational purpose, kindly refer to your financial advisor before initiating any trades. Feedback welcome. Thanks & Regards
Let the 1hour candle close above the breakout level and then go for swing trade. Perfect level of buying 303, Can accumulate up to 291 with Strict sl at 288.
Sparc looks quite promising on weekly , daily as well as hourly , volume is ramping up , keep any eye. Simple price action, no jazz!
Buy SPARC cmp 248 buy if it comes down till 210 levels sl 175 target 413 #syed.ibrahim27
i know the price is very far from 217 and also there are chances of stock giving a move towards 160. if someone wants to buy sparc it is good time to accumulate . a perfect base at 150-165 levels is made. i will buy the stock only above 217 .
Short Term Cash Buy SPARC @172.35-173.35 SL 168.8 TGT 182 TK cross over + MACD cross over and once it move above VWAP we can see good upside.
Short Term Cash Buy SPARC @175.00-176 SL 169.20 TGT 188 CROSS OVER on MACD followed by TK and good volume so go LONG.
Short Term Cash Buy SPARC @167.50-168.50 SL 161 TGT 182 Cross over on VWAP and TK line above so good volume buy